Phenotypical and Functional Characteristics of Human Regulatory T Cells during Ex Vivo Maturation from CD4+ T Lymphocytes
Source abstract
Abstract
Regulatory T cells (Tregs) participate in the negative regulation of inflammatory reactions by suppressing effector cells. In a number of autoimmune disorders, the suppressive function and/or the number of Tregs is compromised. The lack of active functioning Tregs can be restored with adoptive transfer of expanded ex vivo autologous Tregs. In our study, we traced the differentiation and maturation of Tregs CD4+CD25+FoxP3+CD127low over 7 days of cultivation from initial CD4+ T cells under ex vivo conditions. The resulting ex vivo expanded cell population (eTregs) demonstrated the immune profile of Tregs with an increased capacity to suppress the proliferation of target effector cells. The expression of the FoxP3 gene was upregulated within the time of expansion and was associated with gradual demethylation in the promotor region of the T cell-specific demethylation region. Real-time RT-PCR analysis revealed changes in the expression profile of genes involved in cell cycle regulation. In addition to FOXP3, the cells displayed elevated mRNA levels of Ikaros zinc finger transcription factors and the main telomerase catalytic subunit hTERT. Alternative splicing of FoxP3, hTERT and IKZF family members was demonstrated to be involved in eTreg maturation. Our data indicate that expanded ex vivo eTregs develop a Treg-specific phenotype and functional suppressive activity. We suggest that eTregs are not just expanded but transformed cells with enhanced capacities of immune suppression. Our findings may influence further development of cell immunosuppressive therapy based on regulatory T cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: T-cell and B-cell Immunology · Immune Cell Function and Interaction · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Biomedical Chemistry, Pogodinskaya St. 10/8, 119121 Moscow, Russia
Department of Biochemistry, Peoples Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6, 117198 Moscow, Russia
Research Center of Neurology, Volokolamskoe Shosse, 80, 125367 Moscow, Russia
References (82)
Show source-provided references
1. Human CD4+CD25(high)CD127 (low/neg) regulatory T cells10.1007/978-1-61779-367-7_20 ↗
2. Regulatory T cell lineage specification by the forkhead transcription factor foxp310.1016/j.immuni.2005.01.016 ↗
3. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells10.1038/ni904 ↗
4. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases10.4049/jimmunol.155.3.1151 ↗
5. Polar opposites: Erk direction of CD4 T cell subsets10.4049/jimmunol.1103015 ↗
6. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp310.1038/ni1437 ↗
7. Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H.-D., Bopp, T., and Schmitt, E. (2007). Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol., 5.10.1371/journal.pbio.0050038 ↗
8. Ex Vivo-Expanded but Not In Vitro-Induced Human Regulatory T Cells Are Candidates for Cell Therapy in Autoimmune Diseases Thanks to Stable Demethylation of the FOXP3 Regulatory T Cell-Specific Demethylated Region10.4049/jimmunol.1401145 ↗
9. Ikaros Zinc Finger Transcription Factors: Regulators of Cytokine Signaling Pathways and CD4(+) T Helper Cell Differentiation10.3389/fimmu.2019.01299 ↗
10. Telomerase in T lymphocytes: Use it and lose it?10.4049/jimmunol.178.11.6689 ↗
11. Plyasova, A.A., and Zhdanov, D.D. (2021). Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes. Biomedicines, 9.10.3390/biomedicines9050526 ↗
12. Alternative Splicing of FOXP3-Virtue and Vice10.3389/fimmu.2018.00530 ↗
13. Expression of aberrantly spliced oncogenic Ikaros isoforms coupled with clonal IKZF1 deletions and chimeric oncogenes in acute lymphoblastic leukemia10.1016/j.bcmd.2018.02.001 ↗
14. CTLA-4 is a second receptor for the B cell activation antigen B710.1084/jem.174.3.561 ↗
15. CTLA-4 control over Foxp3+ regulatory T cell function10.1126/science.1160062 ↗
16. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II10.4049/jimmunol.180.9.5916 ↗
17. LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites10.4049/jimmunol.0903879 ↗
18. Murine regulatory T cells induce death of effector T, B, and NK lymphocytes through a contact-independent mechanism involving telomerase suppression and telomere-associated senescence10.1016/j.cellimm.2018.06.008 ↗
19. Contact-independent suppressive activity of regulatory T cells is associated with telomerase inhibition, telomere shortening and target lymphocyte apoptosis10.1016/j.molimm.2018.07.017 ↗
20. Multiple immuno-regulatory defects in type-1 diabetes10.1172/JCI0213605 ↗
21. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis10.4049/jimmunol.172.10.6435 ↗
22. Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission10.1191/0961203303lu368oa ↗
23. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus10.4049/jimmunol.178.4.2579 ↗
24. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus10.1007/978-0-387-72005-0_12 ↗
25. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level10.1111/j.1365-2567.2007.02690.x ↗
26. Tolerance to islet autoantigens in type 1 diabetes10.1146/annurev.immunol.19.1.131 ↗
27. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis10.4049/jimmunol.169.9.4712 ↗
28. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice10.1073/pnas.172382999 ↗
29. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation10.1084/jem.20020399 ↗
30. Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes10.1182/blood-2004-09-3579 ↗
31. Immunotherapy with regulatory T cells in transplantation10.2217/imt.09.45 ↗
32. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells10.1182/blood-2004-01-0086 ↗
33. Golovina, T.N., Mikheeva, T., Brusko, T.M., Blazar, B.R., Bluestone, J.A., and Riley, J.L. (2011). Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS ONE, 6.10.1371/journal.pone.0015868 ↗
34. Ex vivo expanded regulatory T cells CD4(+)CD25(+)FoxP3(+)CD127(Low) develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis10.1080/08916934.2016.1199020 ↗
35. Apoptotic endonuclease EndoG inhibits telomerase activity and induces malignant transformation of human CD4+ T cells
36. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue10.1158/0008-5472.CAN-08-2361 ↗
37. Specific association of human telomerase activity with immortal cells and cancer10.1126/science.7605428 ↗
38. Apoptotic endonuclease EndoG regulates alternative splicing of human telomerase catalytic subunit hTERT
39. Helios-controller of Treg stability and function10.21037/tcr.2016.07.37 ↗
40. Treg and CTLA-4: Two intertwining pathways to immune tolerance10.1016/j.jaut.2013.06.006 ↗
41. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression10.1182/blood-2006-12-064527 ↗
42. Role of LAG-3 in Regulatory T Cells10.1016/j.immuni.2004.08.010 ↗
43. Molecular mechanisms involved in the aging of the T-cell immune response10.2174/138920212803759749 ↗
44. Alternative splicing of telomerase catalytic subunit hTERT generated by apoptotic endonuclease EndoG induces human CD4 + T cell death10.1016/j.ejcb.2017.08.004 ↗
45. Regulation of Telomerase Activity10.1134/S2079086418020068 ↗
46. Apoptotic endonuclease EndoG induces alternative splicing of telomerase catalytic subunit hTERT and death of tumor cells
47. Slusher, A.L., Kim, J.J.J., and Ludlow, A.T. (2020). The role of alternative rna splicing in the regulation of htert, telomerase, and telomeres: Implications for cancer therapeutics. Cancers, 12.10.3390/cancers12061514 ↗
48. Transcriptional regulation of Foxp3 in regulatory T cells10.1016/j.imbio.2010.11.002 ↗
49. The role of the Ikaros gene in lymphocyte development and homeostasis10.1146/annurev.immunol.15.1.155 ↗
50. Zhao, W., Li, Y., Yao, C., Zhang, G., Zhao, K.Y., Chen, W., Ru, P., Pan, X., Tu, H., and Jones, D. (2020). Detection of Pathogenic Isoforms of IKZF1 in Leukemic Cell Lines and Acute Lymphoblastic Leukemia Samples: Identification of a Novel Truncated IKZF1 Transcript in SUP-B15. Cancers, 12.10.3390/cancers12113161 ↗
51. Analysis of Ikaros family splicing variants in human hematopoietic lineages
52. Mammalian cell-cycle regulation: Several Cdks, numerous cyclins and diverse compensatory mechanisms10.1038/onc.2009.170 ↗
53. Human regulatory T cells induce T-lymphocyte senescence10.1182/blood-2012-03-416040 ↗
54. Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors10.1016/j.cell.2005.02.003 ↗
55. ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest10.1038/sj.onc.1207467 ↗
56. HUS1 regulates in vivo responses to genotoxic chemotherapies10.1038/onc.2015.118 ↗
57. Ki-67: More than a proliferation marker10.1007/s00412-018-0659-8 ↗
58. Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest10.1093/mutage/geq026 ↗
59. Chk1 Promotes DNA Damage Response Bypass following Oxidative Stress in a Model of Hydrogen Peroxide-Associated Ulcerative Colitis through JNK Inactivation and Chromatin Binding10.1155/2017/9303158 ↗
60. In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells10.1038/nprot.2007.258 ↗
61. Generation of induced regulatory T cells from primary human naïve and memory T cells
62. Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells10.4049/jimmunol.178.7.4022 ↗
63. Methylation matters: Binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells10.1007/s00109-010-0642-1 ↗
64. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells10.4049/jimmunol.178.4.2018 ↗
65. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad710.4049/jimmunol.172.9.5149 ↗
66. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development10.1016/j.immuni.2012.09.010 ↗
67. DNA methylation controls Foxp3 gene expression10.1002/eji.200838105 ↗
68. Expression of Helios in peripherally induced Foxp3+ regulatory T cells10.4049/jimmunol.1102964 ↗
69. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment10.1126/science.1439790 ↗
70. Ikaros fingers on lymphocyte differentiation10.1007/s12185-014-1644-5 ↗
71. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells10.1016/j.molimm.2010.02.001 ↗
72. Zabransky, D.J., Nirschl, C.J., Durham, N.M., Park, B.V., Ceccato, C.M., Bruno, T.C., Tam, A.J., Getnet, D., and Drake, C.G. (2012). Phenotypic and functional properties of Helios+ regulatory T cells. PLoS ONE, 7.10.1371/journal.pone.0034547 ↗
73. The Role of the Ikaros Family of Transcription Factors in Regulatory T cell Development and Function10.4172/2155-9899.1000495 ↗
74. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors10.1128/MCB.01839-06 ↗
75. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells10.1126/science.1176077 ↗
76. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization10.1016/S0092-8674(00)80538-3 ↗
77. The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis10.1158/0008-5472.CAN-12-3082 ↗
78. Inhibition of telomerase activity by splice-switching oligonucleotides targeting the mRNA of the telomerase catalytic subunit affects proliferation of human CD4+ T lymphocytes10.1016/j.bbrc.2018.12.186 ↗
79. Regulation of the human catalytic subunit of telomerase (hTERT)10.1016/j.gene.2012.01.095 ↗
80. Saebøe-Larssen, S., Fossberg, E., and Gaudernack, G. (2006). Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): Analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol. Biol., 7.10.1186/1471-2199-7-26 ↗
81. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium10.1002/(SICI)1097-0215(20000201)85:3<330::AID-IJC6>3.0.CO;2-U ↗
82. Break-induced replication and telomerase-independent telomere maintenance require Pol3210.1038/nature06047 ↗